JS004
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for JS004, covering 2023-08-01 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors [Phase 1]